Febuxostat tablets 80 mg
Drug Details
- Generic Name
- Febuxostat tablets 80 mg
- Brand Names
- Febuxostat
- Application Number
- ANDA207293
- Sponsor
- Macleods Pharmaceuticals Limited
- NDC Codes
- 1
- Dosage Forms
- FILM
- Routes
- ORAL
- Active Ingredients
- FEBUXOSTAT
Indications and Usage
1 INDICATIONS & USAGE Febuxostat is a xanthine oxidase (XO) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable. Limitations of Use: Febuxostat is not recommended for the treatment of asymptomatic hyperuricemia. Febuxostat tablets is a xanthine oxidase (XO) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable. Limitations of Use: Febuxostat tablet is not recommended for the treatment of asymptomatic hyperuricemia.